Your session is about to expire
← Back to Search
Behavioural Intervention
Participants receiving A-CHESS for Alcoholic Liver Disease
N/A
Waitlist Available
Led By Robert S Brown, MD, MPH
Research Sponsored by New York Presbyterian Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if a smartphone app can help decrease alcohol relapse rates for people with alcoholic liver disease.
Eligible Conditions
- Alcoholic Liver Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Rates of recidivism
Secondary study objectives
Use of A-CHESS
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Participants receiving A-CHESSExperimental Treatment1 Intervention
Participants will be provided access to the smartphone application A-CHESS (intervention) that will be downloaded to their phone.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
A-CHESS
2020
N/A
~70
Find a Location
Who is running the clinical trial?
New York Presbyterian HospitalLead Sponsor
75 Previous Clinical Trials
48,808 Total Patients Enrolled
University of Wisconsin, MadisonOTHER
1,221 Previous Clinical Trials
3,167,455 Total Patients Enrolled
Robert S Brown, MD, MPHPrincipal InvestigatorWeill Cornell Medical College/NYPH
3 Previous Clinical Trials
633 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger